Publications
Advancing cardiology research is not just about understanding the heart—it's about unlocking the potential to save lives, improve quality of care, and shape a healthier future.
By participating in clinical trials and exploring new treatments, we stay at the forefront of innovation. This helps to advance the latest therapies and care approaches to improve patient outcomes.
We believe in working together to improve patient outcomes. By sharing practical, evidence-based knowledge, we aim to strengthen the partnership between GPs and cardiologists, ensuring patients receive seamless, high-quality care at every stage of their cardiac journey.
Dr Amera Halabi
Effects of dapagliflozin on the progression of left ventricular dysfunction in type 2 diabetes mellitus: a randomized controlled trial.
Cardiovasc Diabetol. 2025;24:232.
Dr Amera Halabi
The heart in diabetic hypertensive patients. Updates in hypertension and cardiovascular protection.
Springer Nature. 2022;Chapter 13.
Dr Amera Halabi
Association of biomarkers and risk scores with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus.
Cardiovasc Diabetol. 2022;21(1):278.
Dr Kawa Haji
Development of an acute coronary syndrome–cardiogenic shock risk score for 30-day mortality from the Victorian Cardiac Outcomes Registry (VCOR ACS-CS Risk Score).
Catheter Cardiovasc Interventions. 2025 Jul;106(1):303-316.
Dr Kawa Haji
Association of Cognitive Impairment With Evolution of Heart Failure.
Journal of the American Heart Association. 2025;14(15).
Dr Kawa Haji
Clinical features, and outcomes among patients with refractory out-of-hospital cardiac arrest and an initial shockable rhythm.
Cardiovascular Interventions. 2023
Mr Andrew Newcomb
Device encapsulated MSCs for adaptive secretome therapy to effectively target ischaemic heart injury.
BioRxiv. 2025.
Mr Andrew Newcomb
Atrial fibrillation surgery in Australia: are we doing enough?
Heart Lung Circulation. 2024 Dec;33(12):1627-1637.
Mr Andrew Newcomb
Do rapid-deployment surgical aortic valve replacements offer an effective and safe treatment for patients with isolated aortic disease? A decade's experience from a single centre.
Heart and Lung Circulation. 2024 Jun;33(Suppl 1):S15–S16.
Mr Adam Zimmet
Short-term outcomes of valve-in-valve transcatheter aortic valve implantation from the ACE-TAVI Registry.
Heart and Lung Circulation. 2025;34.
Mr Adam Zimmet
Routine Protamine Administration for Bleeding in Transcatheter Aortic Valve Implantation: The ACE-PROTAVI Randomized Clinical Trial.
JAMA Cardiology. 2024 Oct 1;9(10):901-908.
Mr Adam Zimmet
Predictors of late atrial fibrillation recurrence after cardiac surgery.
JACC: Clinical Electrophysiology. 2024 Jul;10(7 Pt 2):1711–1719.
Dr Anuradha Aggarwal
Basis for a sympatholytic approach in the treatment of human heart failure.
PhD Thesis. 2017.
Dr Anuradha Aggarwal
Marantic endocarditis presenting as recurrent arterial embolisation.
International Journal of Cardiology. 2009 Feb 6;132(1):e14–e16.
Dr Daniel Gayed
Associations Between Dual Antiplatelet Therapy Score and Long-Term Mortality After Percutaneous Coronary Intervention: Analysis of More Than 27,000 Patients.
Canadian Journal of Cardiology. 2024.
Dr Daniel Gayed
Outcomes of thrombus aspiration during primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Internal Medicine Journal. 2022 Jun 7.
Dr Daniel Gayed
Left ventricular hypertrophy in experimental chronic kidney disease is associated with reduced expression of cardiac Kruppel-like factor 15.
BMC Nephrology. 2018 Jul 3;19(1):159.
Dr Deepak Haikewral
Early discharge to clinic-based therapy of patients presenting with decompensated heart failure (EDICT-HF): study protocol for a multi-centre randomised controlled trial.
Heart and Lung Circulation. 2023;33.
Dr Deepak Haikewral
Healthcare services use by patients with heart failure in Australia: Findings from the SHAPE study.
Australian Journal of General Practice. 2022;51:713–720.
Dr Deepak Haikewral
Clinical characteristics of people with heart failure in Australian general practice: results from a retrospective cohort study.
ESC Heart Failure. 2021;8.
Dr Gareth Wynn
Oldest-in-human successful extraction experience of a novel substernal extravascular defibrillator.
Journal of Cardiovascular Electrophysiology. 2024;36(1), 295–297.
Dr Gareth Wynn
A case of very early lead fracture in an implantable cardioverter-defibrillator: management and follow-up.
Pacing and Clinical Electrophysiology. 2024;48(1), 68–71.
Dr Gareth Wynn
Bringing big data to vascular complications during atrial fibrillation ablation
Journal of Cardiovascular Electrophysiology. 2024;35(8):1663–1664.
Dr Jeremy Pereira
Resumption of work after acute coronary syndrome or coronary artery bypass graft surgery
Heart, Lung and Circulation. 2014;23(5):444–453.
Dr Jeremy Pereira
Spontaneous omental bleeding in the setting of dual anti-platelet therapy with ticagrelor.
Heart, Lung and Circulation. 2014;Apr;23(4):e115–e117.
Dr Jeremy Pereira
Giant single coronary system with coronary cameral fistula diagnosed on multislice CT.
International Journal of Cardiology. 2006;106:276–278.
Dr Michael Jones
Collections in the expanded field: relationality and the provenance of artefacts and archives.
Heritage. 2019;2(1):884–897.
Dr Michael Jones
A pacemaker magnet check alone is sufficient for the majority of patients post-pacemaker implant.
Pacing and Clinical Electrophysiology. 2014;37(12):1619–1623.
Dr Michael Jones
Inter- and intravein differences in cardiac output with cardiac resynchronization pacing using a multipolar LV pacing lead
Pacing and Clinical Electrophysiology. 2014;38(2):267–274.
Dr Pupalan Iyngkaran
Old, the new, more or less and the conundrum for biomarkers in cardiovascular diseases?
World Journal of Clinical Cases. 2024;12(28):6244-6246.
Dr Pupalan Iyngkaran
Effectiveness of self-management programmes for heart failure with reduced ejection fraction: a systematic review protocol.
BMJ Open. 2024;14(6):e079830.
Dr Pupalan Iyngkaran
Barriers to cardiac rehabilitation among patients diagnosed with cardiovascular diseases—a scoping review.
International Journal of Environmental Research. 2024;21(3):339.
Dr Su Ling Tee
Impact of late referral on cardiac transplant outcomes.
Heart, Lung and Circulation. 2022;31(11):1524–1530.
Dr Su Ling Tee
Incidence and predictors of eosinophilic myocardial hypersensitivity in patients receiving home dobutamine.
Journal of Cardiovascular Pharmacology. 2022;Oct;80(4):623–628.
Dr Su Ling Tee
Acute pleiotropic effects of dapagliflozin in type 2 diabetic patients with heart failure with reduced ejection fraction: a crossover trial
ESC Heart Failure. 2021;Oct;8(5):4346–4352.
Prof. William Chan
Performing risk adjustment in observational datasets to compare coronary artery bypass grafting vs percutaneous coronary intervention in patients with left ventricular systolic dysfunction.
European Heart Journal. 2025;Aug;46(31):3127–3128.
Prof. William Chan
Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy
European Heart Journal. 2025;Jan;46(1):72–80.
Prof. William Chan
GDF-15 and myocardial remodelling in HFpEF: a comparative analysis with non-cardiac dyspnoea.
Heart, Lung and Circulation. 2025;Aug;34:S672–S673.
Dr Yusuke Sata
Catheter-based renal denervation: 9-year follow-up data on safety and blood pressure reduction in patients with resistant hypertension.
Hypertension. 2023;Apr;80(4):811–819.
Dr Yusuke Sata
Ambulatory arterial stiffness index as a predictor of blood pressure response to renal denervation.
Hypertension. 2018;Jun;36(6):1414–1422.
Dr Yusuke Sata
Role of the sympathetic nervous system and its modulation in renal hypertension.
Frontiers in Medicine. 2018;Mar;5:82.
Our Cardiology Team
Delivering world class cardiology care
Looking for more information or want to book an appointment with a cardiologist?
Taking care of hearts since 2001.